Search Within

Gregory J Riely

Formats
  1. Journal Article (295)
  2. Meeting Abstract (265)
  3. Book Section (16)
  4. Guidelines (15)
  5. Conference Paper (4)
  6. Review (4)
  7. Editorial (3)
  8. Book Whole (1)
  9. Correspondence (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (605)
  2. Solid Tumor Oncology Division (605)
  3. Thoracic Oncology (605)
  4. Department of Pathology and Laboratory Medicine (262)
  5. GSK Faculty (248)
  6. Human Oncology and Pathogenesis Program (223)

More Groups

People
  1. Mark Kris (222)
  2. Marc Ladanyi (188)
  3. Helena Yu (108)
  4. Maria Arcila (85)
  5. Vincent Miller (79)
  6. Charles Rudin (76)

More People

Years
  1. 2025 (9)
  2. 2024 (25)
  3. 2023 (45)
  4. 2022 (39)
  5. 2021 (41)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (157)
  2. Journal of Thoracic Oncology (113)
  3. Clinical Cancer Research (46)
  4. Annals of Oncology (32)
  5. Journal of the National Comprehensive Cancer Network (26)
  6. Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (175)
  2. Elsevier Inc. (137)
  3. American Association for Cancer Research (77)
  4. Oxford University Press (39)
  5. Harborside Press (26)
  6. Elsevier Science, Inc. (23)

More Publishers

Results (605)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of intratumoral microbiome on immunotherapy treatment outcomes in patients with advanced non-small cell lung cancer
    Meeting Abstract

    Elkrief, A.; Bowman, A.; Rizvi, H.; Hellmann, M.; Riely, G. J.; Schoenfeld, A. J.; Ladanyi, M.; Vanderbilt, C. M.
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Phase I/II study of mobocertinib in EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): Updated results from platinum-pretreated patients (PPP)
    Meeting Abstract

    Ramalingam, S. S.; Zhou, C.; Kim, T. M.; Yang, J. C. H.; Riely, G. J.; Mekhail, T.; Nguyen, D.; Campelo, M. R. G.; Felip, E.; Misch, D.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Clinical trial participation among older adult Medicare fee-for-service beneficiaries with cancer
    Journal Article

    Green, A. K.; Tabatabai, S. M.; Aghajanian, C.; Landgren, O.; Riely, G. J.; Sabbatini, P.; Bach, P. B.; Begg, C. B.; Lipitz-Snyderman, A.; Mailankody, S.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Mobocertinib (TAK-788) beim metastasierten EGFR exon 20 insertions (ex20ins)+ NSCLC: Ergebnisse der platin-vorbehandelten patienten und der EXCLAIM-kohorte einer phase 1/2 -studie
    Meeting Abstract

    Misch, D.; Ramalingam, S.; Zhou, C.; Kim, T. M.; Yang, J. C.; Riely, G.; Mekhail, T.; Nguyen, D.; Garcia Campelo, M. R.; Felip, E.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Clinicopathologic and mutational landscape of BRAF(V600E)-mutant non-small cell lung carcinoma
    Meeting Abstract

    Sui, J. S. Y.; Ladanyi, M.; Rudin, C. M.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Offin, M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRAS(G12C) mutation
    Meeting Abstract

    Spira, A. I.; Riely, G. J.; Gadgeel, S. M.; Heist, R. S.; Ou, S. H. I.; Pacheco, J. M.; Johnson, M. L.; Sabari, J. K.; Leventakos, K.; Yau, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Mobocertinib (TAK-788) in EGFR exon 20 insertion (ex20ins)+ metastatic non-small cell lung cancer (mNSCLC): Treatment (tx) beyond progressive disease (PD) in platinum-pretreated patients (pts) with and without intracranial PD
    Meeting Abstract

    Janne, P. A.; Ramalingam, S. S.; Yang, J. C. H.; Riely, G. J.; Bunn, V.; Jin, S.; Zhou, C.; Camidge, D. R.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Assessing effectiveness of first-line carboplatin, pemetrexed, and pembrolizumab in patients with recurrent/metastatic lung adenocarcinoma
    Meeting Abstract

    Ip, A.; Gutierrez, M.; Warren, M. E.; Pfister, D. G.; Brady, O.; Shen, R. L.; Riely, G. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes of single-agent PD-(L)-1 versus combination with chemotherapy in patients with PD-L1-high (≥ 50%) lung cancer
    Meeting Abstract

    Elkrief, A.; Machado Alessi, J. V.; Ricciuti, B.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Chaft, J. E.; Rudin, C. M.; Riely, G. J.; Kris, M. G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Meeting Abstract

    Choudhury, N. J.; Marra, A.; Yang, S. R.; Falcon, C. J.; Heller, G.; Kris, M. G.; Reis-Filho, J. S.; Riely, G. J.; Yu, H. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save